BP000133-CYT-465: Recombinant Rat Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose dependent inhibition of MC/9 proliferation is less than 10 ug/ml concentration corresponding to a Specific Activity of 100,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000133-CYT-486: Recombinant Human Interleukin-10 (IL-10) Protein, His
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000133-CYT-497: Recombinant Mouse Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant co-stimulation with IL-4 of mouse MC-9 cells was found to be < 2 ug/ml, corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000133-CYT-500: Recombinant Human Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent co-stimulation (with murine IL-4) of MC/9 cells was found to be less than 2.0 ug/ml, corresponding to a specific activity of 5.0?05 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000133-CYT-100: Recombinant Human Interleukin-10 (IL-10) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of MC/9 cells (mouse mast cell line) in the presence of 200 pg/ml IL-4, and is typically 0.3-1.5 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.